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Summary 
 
Aims:  1. To present a narrative review of the currently available alternative 
interventions and materials to formocresol pulpotomy, for the management of 
extensive caries in the primary molar.  2. To produce a clinical protocol for pulp 
therapy techniques in the extensively carious primary molar. 
 
Introduction.  The International Agency for Research on Cancer (IARC) has recently 
classified formaldehyde as carcinogenic to humans.  As formaldehyde is a major 
component of formocresol, a safer alternative should be identified. 
 
Method.  A narrative review of the published literature for primary molar pulp therapy 
techniques was undertaken, following an extensive and appropriate literature search.  
A specialist group of paediatric dentists was formed to arrive at a consensus and 
establish an evidence-based protocol for the management of extensively carious 
primary molar teeth. 
 
Part I of this paper explores the currently available alternative interventions and 
materials to formocresol in the form of a narrative review.  The second part of the 
paper will present the formation of a specialist group to arrive at a consensus and 
establish an evidence based-protocol, for the management of the extensively carious 
primary molar. 
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Conclusion.  After consideration of a review of extensively searched literature a 
protocol and key points document have been developed to assist clinicians in their 
treatment planning.  Further long-term studies with the highest level of evidence  
(Randomised Controlled Trials) are required to enable us to identify acceptable 
alternatives, which can replace formocresol. 
 
Introduction 
The disquiet among the dental profession over the use of formocresol in the 
management of primary teeth has led in the past to the evaluation of possible 
alternatives to the medication. Following the criticism from the Cochrane Review of 
Pulp Therapy [1] regarding the paucity of appropriately designed, statistically 
assessed investigations, and the lack of long term outcomes, many studies have been 
reported and several others begun to contribute to the literature.  
Furthermore the IARC (International Agency for Research on Cancer) in June 2004 
has classified formaldehyde as carcinogenic to humans [2] leaving the profession to 
look for other viable alternatives to formocresol. An expert working group of the 
IARC evaluated the available evidence on the carcinogenicity of formaldehyde, the 
main ingredient in Buckley’s Formocresol solution, which is used as a pulpotomy 
medicament in the management of extensive caries in the primary molar. Based on the 
information made available,  the expert working group has determined that there is 
now sufficient evidence that formaldehyde causes nasopharyngeal cancer in humans, a 
rare cancer in developed countries, limited evidence for cancer of the nasal cavity and 
paranasal sinuses and "strong but not sufficient evidence" for leukaemia.  
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Method 
The different techniques employed to manage the cariously exposed vital primary 
tooth with reversibly inflamed coronal pulp and healthy radicular pulp tissue will be 
reviewed in this section.  The procedure used must result in clinical and radiographic 
success and any techniques or agents used should be biocompatible with the pulp and 
surrounding tissues. 
This is a traditional narrative review, which aims to consider and discuss alternative 
interventions to formocresol as a pulpotomy medicament in primary teeth.  It differs 
from a systematic review in involving general discussion of a subject and has no 
stated hypothesis [3].  An extensive search of the reported literature from January 
1966 to September 2004 was produced using the Medline, Embase and PubMed 
databases.  The search strategy employed key words, which were each of the 
alternatives to formocresol considered in this paper in combination with each other 
and with formocresol.  Although the Cochrane Review of Pulp Therapy covered 
similar ground [1], we hope to review the literature that has been made available since 
the review and also to highlight information, which could have been lost in the rigour 
of the Cochrane review. 
The various procedures and medicaments reported in the literature have been 
previously classified by Ranly [4] according to the treatment objectives.  The 
interventions reported in current literature can also be classified applying the same 
criteria as follows:  devitalisation (formocresol, glutaraldehyde, electrocoagulation), 
preservation (ferric sulphate, calcium hydroxide, mineral trioxide aggregate, lasers) 
and remineralisation (indirect pulp therapy, bone morphogenic proteins, collagen), 
of the dental pulp in the primary molar with extensive caries. In addition to the above 
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interventions our review also includes pulpectomy (root canal therapy), which is 
indicated in teeth with irreversible radicular pulp inflammation. 
 
Review of literature 
 
1. Devitalisation 
Glutaraldehyde 
Glutaraldehyde was proposed as a new pulp tissue fixative by ‘s-Gravenmade in 1975 
[5] and has been reported to be a better tissue fixative than formocresol [6].  This di-
aldehyde has a limited shelf life, cross-linking ability superior to that of formocresol, 
eliciting a different pulpal response to formocresol.  Although this tissue effect is 
indicative of advantages as a pulpotomy agent, such advantages have yet to be 
adequately substantiated.  Systemic distribution from pulpotomy sites [7, 8] 
cytotoxicity [9] and mutagenecity [10, 11] has been reported to be similar to 
formocresol.   
 
Clinical studies have evaluated the use of 2% buffered glutaraldehyde applied for 5 
minutes over the pulp tissue of primary teeth to achieve the fixative effect.  A 98% 
success rate has been reported in a prospective study after a follow up for 19 to 42 
months [12] with equal effectiveness for 1-3 minute applications.  Fuks et al. [13] 
reported a success rate of 94.3% over six months which decreased to 82% after 25 
months which is significantly lower than that reported for formocresol.  Shumayrikh 
and Adenubi [14] reported the overall success rate for glutaraldehyde as 92.9% for an 
IRM dressing and 73.6% for a calcium hydroxide dressing after 12 months.   
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With similar toxic effects as formocresol, and no strong evidence of improved success 
rates, glutaraldehyde has not been accepted as an appropriate alternative to 
formocresol. 
  
Electrosurgery 
Electrosurgery is a non-pharmacological, haemostatic technique used for the 
amputation of the inflamed coronal pulp, prior to placing a lining material [15]. 
Anderman in 1982 [16] described the electrosurgical pulpotomy in primary teeth as a 
time-efficient method that is relatively free from postoperative complications.  In 
electro surgery, different currents producing different amounts of heat may be used to 
produce a surgical incision, coagulation or electrofulguration (destruction of tissue by 
electric sparks).  The procedure carbonises and denatures the pulp tissue, producing a 
layer of coagulative necrosis, which acts as a barrier between the lining base material 
placed and the healthy  radicular tissue beneath. 
 
Electro coagulation has been evaluated and compared to formocresol on caries-free 
primary and permanent teeth in primates [17, 18, 19]. These animal studies are of 
limited benefit as in the clinical situation primary molars requiring pulpotomy are 
cariously exposed. It has also been suggested that contaminated pulp tissue might not 
promote adequate current penetration [18].   
 
Conflicting reports have resulted from human clinical trials.  From the study by 
Sheller and Morton [20] it was concluded that the success depended on the pre-
existing pulpal status.  However Mack and Dean [21] reported a high clinical and 
radiographic success rate in a study where teeth were reviewed from one to seventy 
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months, following electrocoagulation pulpotomy. The electrosurgical process cannot 
eliminate inflammation of the radicular pulp.  Therefore, the success of the 
electrosurgical pulpotomy depends on the initial pulp status. 
 
2. Preservation 
Ferric Sulphate 
Ferric sulphate (15.5%) has been investigated widely and reported in animal and 
human studies as a haemostatic agent in pulpotomy procedures.  On contact with 
blood a ferric ion-protein complex is formed, and the membrane of this complex seals 
the cut vessels mechanically producing haemostasis and the agglutinated protein 
complex forms plugs, which occlude the capillary orifices preventing blood clot 
formation [22, 23]. 
 
The first animal study with ferric sulphate was carried out in monkey teeth by Landau 
and Johnsen in 1988 [24] to investigate usage prior to placement of calcium 
hydroxide over amputated pulps.  It was intended to produce haemorrhage control in 
order to improve the efficacy of calcium hydroxide, as it’s failure was attributed to the 
persistence of an extra-pulpal blood clot [25].  Subsequent animal studies were carried 
out in baboons [26] and rats [27].  Fuks and her co-workers compared the pulpal 
responses of ferric sulphate and formocresol in baboon teeth [26].  Outcomes for both 
medicaments were equal after 6 weeks, with 60% of teeth in each group presenting 
with mild inflammation.  Working in rat teeth Cotes and co-workers [27] confirmed 
similar inflammation in response to ferric sulphate and formocresol.  Although there 
was more reparative dentine and fibrosis with ferric sulphate, these findings occurred 
in less than 40% of teeth treated. 
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Fei et al. reported the combined clinical and radiographic success at the end of a one-
year prospective human trial [28] as 96% for ferric sulphate and 78% for formocresol.  
Ibricevic and Al-Jame reported results first at the end of 20 months [29] and later at 
48 months  [30] for teeth treated with ferric sulphate and formocresol. Although 
overall success rates were similar to those from Fuks and co- workers [31] the 
radiographic success rates for ferric sulphate fell from 97.2% after 20 months to 92% 
after 48 months follow up. Despite this, success rates were higher than those reported 
in the two retrospective studies by Burnett and Walker [32] and Smith et al. [33]. 
 
The ferric sulphate used in all the above studies was 15.5% except in the study by 
Casas and Kenny [34] where a 16% ferric sulphate equivalent in an aqueous vehicle 
was evaluated in comparison to pulpectomy (root canal therapy) in primary molars. 
Although at the end of two years this group reported statistically significant success 
rates in favour of root canal therapy in their sample, (teeth recommended for 
extraction: 39% for ferric sulphate and 9% for root canal treatment), at the end of 
three years the same sample size was insufficient to show significant results. 
 
Based on the available evidence so far, ferric sulphate and formocresol produce 
equivalent outcomes.  An evidence-based assessment of clinical trials of ferric 
sulphate and formocresol with Meta analysis [35] concluded that, in human carious 
primary molars with reversible coronal pulpitis, pulpotomies performed with either 
formocresol or ferric sulphate are likely to have similar clinical/radiographic success. 
This finding agreed with the Cochrane Systematic Review [1] of the pulp treatment 
for extensive decay in primary teeth. 
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Calcium hydroxide 
Calcium hydroxide has been proposed as an alternative to formocresol for 
pulpotomies in primary teeth [36].  The main drawback of this alternative intervention 
is internal resorption, which was thought to be stimulated by calcium hydroxide.  As 
the observed resorption has been ascribed to a blood clot intervening between the 
material itself and the pulp tissue various attempts have been made unsuccessfully, to 
prevent the formation of the extra-pulpal blood clot. These included minimizing the 
trauma to major pulp vessels and the resultant clots by performing a partial pulpotomy 
[25, 37], use of a haemostatic agent prior to the placement of calcium hydroxide [24, 
38], and pulp amputation by electrocoagulation [39]. 
 
Various animal studies have been carried out to evaluate the pulpal response to 
calcium hydroxide, but as several animal models have been utilised comparison is 
difficult. The consensus of opinion from these studies appears to be that complete and 
incomplete dentine bridges are formed in amputated pulps beneath calcium 
hydroxide, which are similar in morphology to osteodentine.  Beyond the calcific 
bridge is found a fibrous layer and vital pulp tissue [40, 41, 42]. 
 
Published data regarding the degree of clinical success of calcium hydroxide vital 
pulpotomy technique are varied.  A success rate of 70% was obtained using a thick 
paste of calcium hydroxide and water as reported by Teuscher and Zander [43].  Via 
[44] Schröder [25, 37] and Doyle et al. [36] concluded that the calcium hydroxide 
treatment was associated with dentine bridge formation and complete healing of the 
stump of the amputated primary dental pulp; however, when the treatment failed 
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internal resorption was the cause. There was no such dentine bridge or healing process 
seen with formocresol in these studies. 
 
Magnusson [45] obtained less successful results, with 12% clinical and 33% 
radiographic success from 120 pulpotomies in primary mandibular molars. 
Waterhouse et al.  [46] reported a statistically insignificant difference in treatment 
outcomes between formocresol and calcium hydroxide pulpotomy.  This group of 
workers implemented strict tooth selection criteria in their study i.e., absence of 
clinical signs and symptoms of coronal and radicular pulp necrosis including lack of 
spontaneous pain in addition to absence of radiographic signs of pulp necrosis. 
Working only within this remit of tooth selection criteria they concluded that calcium 
hydroxide in its pure powder form was a clinically acceptable alternative to 
formocresol.  
 
Mineral trioxide aggregate 
Mineral trioxide aggregate (MTA) was first described in the dental literature in 1993 
[47] for repair of lateral root perforations.  Since then the material has been evaluated 
in animal models for several applications in dentistry including root end filings [48, 
49], direct pulp caps [50, 51, 52], perforation repair in furcations [53, 54] and 
apexification [55, 56]. These histological animal studies report optimum 
biocompatibility with the periapical tissues [48, 49] and the pulp [50, 51, 52] in 
addition to the material’s sealing ability [49]. 
 
MTA (Pro Root, Dentsply, Tulsa Dental) is available as Pro Root Gray or  Pro Root 
White [57]. White Pro Root has been introduced as an aesthetic improvement over the 
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original material, for placement in anterior teeth.  The major components of White 
MTA are tricalcium silicate, dicalcium silicate, tricalcium aluminate, calcium sulphate 
dehydrate and bismuth oxide (Dentsply Tulsa Dental, 2001).  The manufacturer 
however does not disclose the ingredients responsible for masking the greyness of the 
original Pro Root. 
 
Torabinejad et al. [58] have described some of the physical and chemical properties of 
MTA.  MTA is biocompatible and provides a better seal than zinc oxide-eugenol and 
amalgam. It is available in powder form, which sets in the presence of moisture, with 
a setting time of four hours.  Koh et al. [59] demonstrated that MTA has the ability to 
stimulate cytokine release from bone cells, indicating that it actively promotes hard 
tissue formation.  Torabinejad and Chivian [60] proposed MTA as a potential 
medicament for pulpotomy procedures as well as capping of pulps with reversible 
pulpitis in addition to many other applications in dentistry. 
 
MTA was first tested on traumatically exposed pulps in monkey teeth as a pulp 
capping material and found to produce favourable results [61].  No pulpal 
inflammation was observed after five months in comparison to calcium hydroxide, 
which elicited pulpal inflammation in all samples. 
 
Eidelman and co workers [62] reported a study in which MTA was compared to 
formocresol. Follow up evaluation was reported for a period ranging from six to 30 
months and revealed only one failure in a molar treated with formocresol and no 
failures in teeth treated with MTA.  Although pulp canal obliteration was observed in 
two out of 15 teeth treated with formocresol (13%) and seven out of 17 teeth treated 
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with MTA (41%), it was not regarded as an unfavourable outcome. Although the 
sample sizes were small, MTA was proposed as a suitable alternative to formocresol 
in primary teeth. 
 
More recently Agamy et al. [63] reported a prospective clinical trial comparing White 
MTA, Gray MTA and formocresol.  Gray MTA appeared to be superior to both white 
MTA and formocresol as a pulp dressing for pulpotomised primary teeth. This study 
found a high percentage of pulp canal obliteration (58% with the Gray MTA, and 5% 
with white MTA), but no obliteration in the group treated with formocresol. There 
was a significant difference in the clinical and radiological outcomes between the 
White MTA group and the Gray MTA group, with the latter performing better.  
However, comparable outcomes were achieved with the white MTA and formocresol 
at the end of 12 months.  Histologically, both types of MTA successfully induced a 
thick dentine bridge at the amputation sites, while formocresol induced thin, poorly 
calcified dentine. 
 
The lack of internal resorption in the above studies in the teeth treated with MTA 
contrasts with the studies that reported internal resorption in response to zinc oxide 
eugenol [64], ferric sulphate [33, 31], and calcium hydroxide [36, 38]. The lack of 
internal resorption in addition to the biocompatibility, sealing ability and promotion of 
hard tissue formation seem to favour further research involving long-term follow up 
on the use of MTA for pulp therapy in primary molars. 
 
Presently, a drawback to the clinical use of MTA is it’s cost relative to other agents, 
and perceived problems with its storage.  A carton of Pro-Root MTA contains, 5-one 
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gramme sachets of the material costing approximately £ 121.45 (Є 178.00, US $ 
232.52). The composition of MTA is similar to that of the cement used in the building 
industry to make concrete. Such a material should be kept dry during storage as moist 
air leads to the phenomenon of air setting [65], which reduces the strength of the mix. 
Once such a material is opened from the air-seal packaging, it should be sealed in an 
air-tight and water-proof container. Significant strength losses begin to occur after 
four to six weeks. The same could be applied to the MTA when used in dentistry. The 
manufacturer recommends the marketed 1 gramme sachet for single use, which would 
result in considerable wastage of the material. Once the sachet is opened and the 
required amount used, the remaining material may be stored up to four weeks in a 
water and airtight container such as an Eppendorf tube (Eppendorf UK Ltd, Personal 
Communication J M Whitworth, 2004).  
 
 
Lasers 
Since the development of the Ruby laser in 1960, different forms of lasers have been 
evaluated in animal studies for their applications in dentistry. However, their use in 
pulpotomies was first published in 1985 when Shoji et al. [66] evaluated the carbon 
dioxide laser in canine models. 
 
Subsequent studies showed conflicting results with respect to pulpal healing following 
laser pulpotomy [67, 68, 69]. While Shoji et al. [66] reported no detectable change in 
the radicular portion of the pulps, Wilder-Smith and Dang et al. [68] found that 
secondary dentine was formed and a regular odontoblast layer was present. A carbon 
dioxide laser was compared to the ND:YAG laser by Jukic et al. [70], who reported 
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that laser irradiation caused carbonisation, necrosis, inflammatory infiltration, oedema 
and haemorrhage in the pulpal tissues.  Further animal studies have been published 
evaluating other types of lasers, i.e., Nd: YAG lasers [71, 72], GA As laser [73], 
Argon laser [74] and Er: YAG laser [75].  The results from the different animal 
studies have been conflicting with respect to histological evidence of repair with a 
newly formed dentinal bridge. 
 
The only randomised controlled human clinical trial using a laser pulpotomy 
technique involved caries-free primary cuspids, which were scheduled for serial 
extraction [76].  These teeth were subjected to either formocresol or carbon dioxide 
laser pulpotomy. The teeth were evaluated clinically and radiographically at 28 and 
90 days and histologically after extraction.  Carbon dioxide laser treatment compared 
favourably to formocresol for pulpotomy in primary teeth. 
 
Although animal studies have been carried out, further human clinical trials are 
recommended, which will take the use of laser for pulpotomy in primary molars into 
the next stage of research. 
 
Ledermix 
Ledermix (Lederle Pharmaceuticals, Wolfrathausen, Germany) contains the steroid 
triamcinolone acetonide as its primary active component and the broad-spectrum 
antibiotic calcium demethylchlortetracycline. The product is available as a single tube 
cream and two-component tube cement.  
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In the canine model Ledermix has been evaluated for its effect on the pulp tissue 
exposed as a result of trauma (77) in comparison to formocresol, which is a fixative; 
tetrandrine, which is a bibenzylisoquinoline alkaloid with broad-spectrum anti-
inflammatory properties, with saline as a control.  Histological evaluation after 3 days 
for acute inflammation (neutrophil infiltration) and 6 weeks for chronic inflammation 
(lymphocytic infiltration) revealed a statistically significant (P> 0.01) difference 
between the medicaments.  Both acute and chronic inflammatory responses were 
achieved in the following ascending order: Tetrandine, Ledermix, Buckley’s 
Formocresol and Saline. 
 
The effects of calcium hydroxide have been compared to a combination of calcium 
hydroxide and Ledermix (78) on cariously exposed canine pulps.  Both these 
interventions showed no difference in inflammation after 7 and thirty days, with no 
inflammation after 90 days.  Other workers (79) also reported similar findings 
in monkey teeth. 
 
The histologic effects of Ledermix cream and cement on the unexposed and 
traumatically exposed pulp in permanent teeth have been reported (80).  The 
histologic changes observed beneath cavities without pulp exposure were localized to 
the odontoblast-predentine area, and the reactions to the cement were less 
conspicuous than those to the cream.  When placed directly on traumatically exposed 
pulps, preparations rarely produced any histological changes in the soft tissue.  
However moderate to severe inflammation has been reported as a possible response to 
Ledermix, when placed as a wound dressing following pulpotomy in cariously 
exposed vital primary teeth (81). 
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The anti-inflammatory effect of corticosteroids used locally in pulp capping of 
permanent teeth was widely reported in the 1960.  Hansen and co-workers [81] 
reported the only available clinical study of Ledermix as a dressing, to cover the 
pulpal wound following pulpotomy of cariously exposed primary teeth. This study 
compared the effect of Ledermix and zinc oxide eugenol as wound dressings 
following vital pulpotomy in primary molars over an observation period of one to 
forty two months.  Seventy nine percent of the teeth treated with Ledermix and 57% 
of the teeth treated with Zinc oxide eugenol were reported to be clinically and 
radiographically successful.  Teeth exhibiting internal and external resorption were 
deemed as treatment failures and extracted and subsequently evaluated 
histopathologically. Less significant inflammation was observed beneath the pulp 
wounds dressed by Ledermix in comparison to the zinc oxide eugenol group. No 
difference was observed in the inflammation present in the apical part of the roots of 
the teeth studied. 
 
From the literature there appears to be minimal data to support the use of Ledermix as 
a wound dressing following pulpotomy in the primary teeth. 
 
3. Remineralisation 
Indirect Pulp Therapy (IPT) 
Indirect pulp therapy involves the removal of caries, leaving a thin layer of stained 
dentine at the deepest sites of a cavity where complete caries removal would result in 
pulp exposure [82, 83].  Removal of caries from the lateral wall ensures complete 
sealing of the tooth and restorative material interface, thereby isolating the bacteria 
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from their nutrient source, resulting in reduction in their number or death [84, 85, 86, 
87]. 
 
The indication of IPT is limited to teeth that have no signs of irreversible pulp 
pathology based on a clinical and radiographic examination and direct evaluation of 
the cavity preparation [88, 89, 90].  In addition to careful case selection, knowledge of 
tooth anatomy, clinical experience and a good understanding of the process of caries 
progression are required [91].  The use of an antibacterial agent such as calcium 
hydroxide and restoration of the cavity with adequate marginal seal will eliminate any 
bacteria, which remain.  
 
Studies in permanent teeth [92, 93, 94, 95] have reported that the remaining deep 
dentine in teeth treated by indirect pulp therapy is mostly remineralized and hardened.  
These studies suggest that optimal coronal seal prevents caries caries progression 
beneath the restorations.  In view of the thinner dentine in primary teeth compared 
with permanent teeth, re-opening a restoration for removal of the suspected residual 
caries is therefore more likely to cause pulpal exposure, and is hence inappropriate. 
 
A prospective study by Falster et al. [91] in primary molar teeth, where two groups of 
teeth were restored with a composite resin, reported that a total etch technique without 
the placement of a calcium hydroxide lining may produce a similar effect upon 
residual bacteria to that of calcium hydroxide.  All restorations were placed using the 
optimal isolation of dental dam.   Success rates at two years were 96 % for the total 
etch technique and 83 % for the calcium hydroxide lining technique. The high success 
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rate was attributed to the correct diagnosis, case selection, and appropriate restorative 
technique rather than the placement of a calcium hydroxide lining per se. 
 
Two retrospective human clinical studies using IPT in primary teeth, reported success 
rates exceeding 90% over a mean follow-up time of 4.2 years [90] and two weeks to 
73 months [97].  The first group of workers reported a comparative 82% success rate 
for formocresol pulpotomy in comparison to IPT.  IPT is a promising technique, 
which warrants further prospective clinical evaluation. 
 
It is important to appreciate the difference between IPT and Atraumatic Restorative 
Treatment (ART).  ART involves excavating cavitated dentine caries with hand 
instruments only and restoring the cavity with a chemically adhesive restorative 
material and sealing any associated fissures and pits. The technique was initially 
recommended in countries where hightly trained dentists and the electricity needed 
for clinic equipment is not readily available [98].  Although IPT and ART share the  
similar concept of sealing the cavity from the oral environment leading to a reduction 
in the number of microorganisms, ART can be practised in cavitated teeth, especially 
those with single surface decay only. Also glass ionomer cement which is the material 
of choice in the ART, has indadequate physical and mechanical properties which 
influence the long term survival of the restorations. 
 
Bone morphogenic proteins  
Bone morphogenic protein (BMP) is a generic term for a family of proteins that has 
bone inductive properties.  It was observed as early as in 1965, that demineralised 
bone matrix was capable of stimulating bone formation when implanted in ectopic 
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sites [99].  It was concluded that factors capable of autoinduction were present in the 
bone matrix and the term bone morphogenic proteins was proposed. BMP are 
osteogenic proteins, which form part of the Tumour Growth Factor (TGF-β).  They 
are implicated in cell differentiation, tissue morphogenesis, regeneration and repair.  
BMP-like activity has been identified in dentine matrix and BMP genes are expressed 
during tooth development and dentinogenesis [100]. 
 
Promising results have been published in this area of research based on animal models 
in permanent teeth with non-inflamed pulps.  It has been proposed that BMP 
stimulated the induction and differentiation of mesenchymal cells with varying 
degrees of dentine bridge formation [100, 101, 102] in swine, monkey and canine 
teeth.  Although these studies suggest that reparative dentine can be induced on 
contact with BMP, dentine bridge formation itself is not a sign of pulpal healing and 
healing pulps are evident in teeth where dentinal bridge formation does not occur 
[103]. 
 
Collagen 
Collagen products have been evaluated in animal studies as pulp medicaments.  The 
use of cross-linked collagen gel [104], and enriched collagen solution [105, 106], has 
been reported as pulpotomy medicaments in animals.  Varying histological responses 
have been demonstrated including complete regeneration of pulpal tissue and dentine 
bridge formation.  These were experiments carried out on non-inflamed pulps, and not 
a true reflection of the response of a pulp exposed by caries.  However, presently no 
clinical studies have been reported on the use of collagen as a medicament to be used 
as an alternative to formocresol. 
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Pulpotomy Medicaments – Conclusions 
 
From the published data available we conclude that ferric sulphate, MTA and IPT 
appear promising alternatives to the single visit formocresol pulpotomy for cariously 
exposed vital primary molar teeth. Ferric sulphate use is arguably technique sensitive 
and MTA has cost implications.  The use of lasers and electrosurgery is not routine in 
all dental settings and may not be readily available. In view of the promising results 
obtained so far, it’s relatively user-friendly technique for the operator and the patient 
in comparison to ferric sulphate and it’s expense in comparison to MTA, IPT emerges 
as one of the potential alternatives. This is especially so in asymtomatic primary 
molars with no radiographic signs of pathology. However, further research is required 
to increase our knowledge of the clinical efficacy, histological effects and systemic 
impact of all the possible alternatives reviewed here, in addition to providing 
sufficient evidence-base for developing Policy Documents and Guidelines.  Therefore 
long-term studies with the highest level of evidence (Randomised Controlled Trials) 
are required to enable us to identify acceptable alternatives which can replace 
formocresol. 
 
Pulp removal 
 
The final section of this review will consider the available literature on pulpectomy  
 
(root canal therapy) as it could be considered as an option in primary molars with  
 
varying degrees of coronal and radicular inflammation in addition to those with 
necrotic pulp  and there fore non-vital. 
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Pulpectomy 
Previously, teeth with irreversible radicular pathology or necrotic pulp tissue could be 
treated with formocresol in a non-vital pulpotomy technique.  The authors accept that 
this is perhaps no longer an option and hence we must seek alternative non-vital 
techniques. 
 
The aim of pulpectomy is to attempt to retain a tooth that would otherwise be 
extracted, and in doing so prevent space loss and disturbance to the permanent 
dentition [107].  Pulpectomy is indicated where the radicular pulp is non-vital and 
irreversibly inflamed [108].  It is not suitable when there is evidence of extensive 
internal or external root resorption, or if greater than one third of the root length has 
been lost [83].  Single visit pulpectomy is also an acceptable alternative to 
formocresol pulpotomy [34] 
 
A number of root filling materials have been suggested.  An ideal material for root 
canal therapy of the primary molar should resorb at a similar rate to the primary root, 
be rapidly eliminated if accidentally extruded through the apex, harmless to the 
periapical tissues and the succedaneous tooth germ, easy to manipulate in order to fill 
the root canals, easily removable, radiopaque and not result in discolouration of the 
tooth [109].  The most commonly used medicaments for primary molar root canal 
therapy are zinc oxide eugenol paste (ZnOE), iodoform paste and calcium hydroxide.   
 
Pure ZnOE paste has been shown to produce high clinical success rates, which are 
comparable to those of calcium hydroxide [110].  Casas et al. (2004) found that 
survival rates for primary molars treated with ZnOE pulpectomy were significantly 
 22 
greater than those treated with ferric sulphate pulpotomies at three years [34].  Until 
recently, ZnOE has been the material of choice, but concerns have been expressed 
regarding the difference between its rate of resorption and that of the tooth and its 
slow absorption when pushed into the apical tissues [107].  It is not known whether 
this has a significant clinical effect. Some studies have identified patients where use 
of ZnOE in the primary tooth has resulted in deflection of the permanent successor 
[111] and Coll and Sandrian (1996) suggest that this may occur in as many as 20% of 
cases [112].   
 
Several authors have reported the use of KRI paste (Pharmachemie, Haarlem, The 
Netherlands), which is a mixture of iodoform, camphor, parachlorophenol and 
menthol [113, 114].    This medicament resorbs rapidly and does not appear to have 
an adverse effect on the permanent successor.  Its success rates have been reported as 
being between 84-100% [113, 114].  Studies have found unfavourable responses of 
periapical tissues to KRI paste and increased cytotoxicity when compared with ZnOE 
[115, 118].  Maisto’s paste has also been described [115].  It is essentially KRI paste 
with the addition of zinc oxide, thymol and lanolin. 
 
Calcium hydroxide has favourable antibacterial effects, is easily resorbed and causes 
no foreign body reaction.  Mani et al (110) showed high clinical success rates over a 
six-month period and although a depletion of material from the root canals was noted, 
this did not appear to be clinically significant. Recent research [111] has investigated 
the use of a premixed calcium hydroxide and iodoform paste (Vitapex, Neo Dental 
Chemical Products Co, Tokyo, Japan).  This study demonstrated a combined clinical 
and radiographic success rate of 100% for Vitapex in comparison to 78.5% for ZnOE. 
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These high clinical success rates, a lack of toxic effects and deleterious effects on the 
succedaneous tooth combined with its radiopacity and resorbability have lead authors 
to herald this as a near ideal primary tooth filling material [117].   
 
Conclusion 
This review of the currently available literature highlights the advantages and 
disadvantages of the alternative interventions and materials for the management of the 
extensively carious primary molar in comparison to formocresol. The process of the 
literature review promoted debate, which facilitated the development of a local 
clinical protocol. 
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